The Women’s Health Innovation Grants are part of the MLSC’s Women’s Health Initiative. The grants focus on projects with translational potential and preliminary supporting data, but still require a key set of proof-of-concept experiments prior to attracting a commercial partner or spinning out into a new company. Projects could include hiring a postdoc to perform research, working with a CRO, entering into a sponsored research agreement, etc.
Individual grants of up to $300,000 will be awarded to Massachusetts-based women’s health researchers, and up to $3 million is available for the whole program.
The application period will run from Oct. 3, 2022 to Jan. 12, 2023 at 8 p.m. EST.
Eligibility & Evaluation
Eligible applicants must be a full or part-time faculty at a Massachusetts-based research institution proposing a project focused on increasing our understanding of sex and gender differences in biology (that has translational potential) or developing solutions for diseases or conditions that affect women solely, disproportionately, or differently. Funding must be used to support an experiment or experiments that increase(s) the translational opportunity for the technology with a defined goal such as filing patents, securing sponsored research agreement, attracting other industry support, etc.
To evaluate applications, an external panel of scientists from academia and industry with expertise in women’s health and translating early-stage innovations will review applications with an eye towards their value to our understanding of women’s health, the unmet need they are addressing, and the proposed solution, among other criteria.
Please see full list of eligibility requirements and evaluation process.
Deliverables, Confidentiality, and General Conditions
Learn more about the Women’s Health Initiative
R.E.D.: Research Equipment Database
D.A.T.A. (Databases, Algorithms, Tools, and Analyses) Repository
Impact on the Ecosystem
Massachusetts recognizes there has been a lack of development in novel solutions to treat conditions that affect women solely, disproportionately, or differently. This impacts not only patients but also employers and the healthcare system. The consequences are profound, with women more likely to have adverse drug reactions than men, and the lack of effective therapies results in reduced quality of life. The Massachusetts Life Sciences Center aims to support and incentivize translational project teams developing novel solutions in this area of need.
Connect with us to Learn More
If you have any questions regarding the application process, e-mail WomensHealth@masslifesciences.com with the Innovation Grant in the subject line.